|
TBL1XR1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.13810000038173E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.11889999999215E-05 |
| Normal-vs-Stage2 |
7.55840000000729E-05 |
| Normal-vs-Stage3 |
1.65671999999839E-05 |
| Normal-vs-Stage4 |
1.03500000003809E-06 |
| Stage1-vs-Stage2 |
1.979360E-01 |
| Stage1-vs-Stage3 |
3.314200E-01 |
| Stage1-vs-Stage4 |
2.560400E-02 |
| Stage2-vs-Stage3 |
5.945400E-01 |
| Stage2-vs-Stage4 |
6.866200E-01 |
| Stage3-vs-Stage4 |
2.555600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.0666000000169E-06 |
| Normal-vs-AfricanAmerican |
2.468400E-02 |
| Normal-vs-Asian |
7.56620000000874E-05 |
| Caucasian-vs-AfricanAmerican |
6.198600E-01 |
| Caucasian-vs-Asian |
4.913400E-01 |
| AfricanAmerican-vs-Asian |
3.230000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.28240000000369E-05 |
| Normal-vs-Female |
1.69859999954447E-07 |
| Male-vs-Female |
6.468800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.45300000000426E-05 |
| Normal-vs-Age(41-60Yrs) |
4.23949999994733E-06 |
| Normal-vs-Age(61-80Yrs) |
1.12299999999177E-06 |
| Normal-vs-Age(81-100Yrs) |
1.379560E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.291400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.573030E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.605200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.035400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.463400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.942400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.893200E-01 |
| Classical-VS-Follicular |
1.315410E-03 |
| Classical-VS-Other |
4.038200E-01 |
| Classical-VS-Normal |
8.619500E-04 |
| Tall-VS-Follicular |
2.809800E-01 |
| Tall-VS-Other |
7.956600E-01 |
| Tall-VS-Normal |
1.882070E-03 |
| Follicular-VS-Other |
7.341600E-01 |
| Follicular-VS-Normal |
3.83339999965315E-07 |
| Other-VS-Normal |
5.302000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.12220000017638E-07 |
| Normal-vs-N1 |
2.07490000003752E-06 |
| N0-vs-N1 |
3.243800E-01 |
|
|
